• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例用类固醇治疗的重症肌无力病例:关于其作用机制的一些建议

A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.

作者信息

Dandona P, Corkan E J, Sladen G E

出版信息

Postgrad Med J. 1977 Jun;53(620):321-4. doi: 10.1136/pgmj.53.620.321.

DOI:10.1136/pgmj.53.620.321
PMID:887530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2496642/
Abstract

This report deals with a patient with long standing myasthenia gravis treated with a small dose of corticosteroids. The response to treatment was prompt and the post-therapeutic deterioration in function was minimal and cholinergic in nature. It is suggested that the dose of anticholinesterases be reduced concomitantly with the institution of steroid treatment.

摘要

本报告涉及一名长期患重症肌无力且接受小剂量皮质类固醇治疗的患者。治疗反应迅速,治疗后功能恶化程度极小且本质上是胆碱能性的。建议在开始类固醇治疗的同时,相应减少抗胆碱酯酶药物的剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4186/2496642/242b994e3554/postmedj00270-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4186/2496642/242b994e3554/postmedj00270-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4186/2496642/242b994e3554/postmedj00270-0036-a.jpg

相似文献

1
A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.一例用类固醇治疗的重症肌无力病例:关于其作用机制的一些建议
Postgrad Med J. 1977 Jun;53(620):321-4. doi: 10.1136/pgmj.53.620.321.
2
Treatment of myasthenia gravis by long-term alternate-day prednisolone.长期隔日服用泼尼松龙治疗重症肌无力
Taiwan Yi Xue Hui Za Zhi. 1975 Sep;74(9):579-89.
3
The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.人类胆碱酯酶与用于重症肌无力治疗的抗胆碱酯酶之间的相互作用。
Ann N Y Acad Sci. 1966 Jan 26;135(1):287-301. doi: 10.1111/j.1749-6632.1966.tb45477.x.
4
Myasthenia gravis can cause camptocormia.
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):469-70. doi: 10.1136/jnnp-2011-300311. Epub 2011 Sep 20.
5
Letter: Edrophonium in diagnosis of cholinergic crisis.信件:依酚氯铵在胆碱能危象诊断中的应用
Br Med J. 1973 Oct 20;4(5885):173. doi: 10.1136/bmj.4.5885.173.
6
Pseudo-internuclear ophthalmoplegia as a sign of overlapping myasthenia gravis in a patient with 'intractable' hypothyroidism.
Intern Med. 2010;49(1):69-72. doi: 10.2169/internalmedicine.49.2348. Epub 2010 Jan 1.
7
Tensilon test: myasthenia gravis.腾喜龙试验:重症肌无力。
QJM. 2019 Jan 1;112(1):49. doi: 10.1093/qjmed/hcy173.
8
Essentials in the management of myasthenia gravis.重症肌无力的管理要点
Am Fam Physician. 1978 Jun;17(6):95-102.
9
Adverse interaction between steroid hormones and anticholinesterase drugs.类固醇激素与抗胆碱酯酶药物之间的不良相互作用。
Neurology. 1974 May;24(5):442-9. doi: 10.1212/wnl.24.5.442.
10
Cholinesterase inhibitors in myasthenia gravis.重症肌无力中的胆碱酯酶抑制剂
Practitioner. 1966 Mar;196(173):448-53.

本文引用的文献

1
The acetylcholine sensitivity of frog muscle fibres after complete or partial devervation.完全或部分去神经支配后青蛙肌肉纤维的乙酰胆碱敏感性
J Physiol. 1960 Apr;151(1):1-23.
2
AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.重症肌无力神经肌肉传递的电生理研究
J Physiol. 1964 Nov;174(3):417-34. doi: 10.1113/jphysiol.1964.sp007495.
3
President's address. Myasthenia gravis.主席致辞。重症肌无力。
Proc R Soc Med. 1974 Aug;67(8):763-9. doi: 10.1177/003591577406700838.
4
Corticosteroids: a direct effect at the neuromuscular junction.
Neurology. 1974 Nov;24(11):1091-5. doi: 10.1212/wnl.24.11.1091.
5
Benefit from adrenocorticotrophin in myasthenia gravis.重症肌无力患者使用促肾上腺皮质激素的获益。
J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):412-5. doi: 10.1136/jnnp.37.4.412.
6
Maintenance adrenocorticotropic hormone (ACTH) treatment in myasthenia gravis.
Neurology. 1972 Nov;22(11):1160-4. doi: 10.1212/wnl.22.11.1160.
7
Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.
Neurology. 1972 Jun;22(6):603-10. doi: 10.1212/wnl.22.6.603.
8
The use of ACTH and corticosteroids in myasthenia gravis.
Ann N Y Acad Sci. 1971 Sep 15;183:369-74. doi: 10.1111/j.1749-6632.1971.tb30766.x.
9
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.
Lancet. 1975 Mar 15;1(7907):607-9. doi: 10.1016/s0140-6736(75)91886-3.